Attention deficit disorder in adults. Management in primary care

Canadian Family Physician

Volumn 51, Issue JAN., 2005, Pages 53-59

  Kates, Nick ^a  

^a Hamilton HSO Mental Health and Nutrition Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ATOMOXETINE; DESIPRAMINE; DEXAMPHETAMINE; METHYLPHENIDATE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PSYCHOSTIMULANT AGENT; STRATERA; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ANOREXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; CLINICAL EXAMINATION; CLINICAL TRIAL; COMORBIDITY; DATA BASE; DEPRESSION; DRUG EFFICACY; FAMILY; GENERAL PRACTITIONER; HEALTH CARE MANAGEMENT; HUMAN; MEDLINE; MOOD DISORDER; ONSET AGE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT REFERRAL; PHYSICIAN; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PSYCINFO; RATING SCALE; RESTLESSNESS; REVIEW; SELF CONCEPT; SELF ESTEEM; SLEEP DISORDER; SOCIAL SUPPORT; SYMPTOMATOLOGY; TREATMENT PLANNING;

ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY PRACTICE; HUMANS; MEDICAL HISTORY TAKING;

EID: 13444291591     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Lamberg L. ADHD often undiagnosed in adults: appropriate treatment may benefit work, family, social life. JAMA 2003;290:1565-7.
2. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105(5):1158-70.
3. Wender PH. Attention-deficit hyperactivity disorder in adults. New York, NY: Oxford University Press; 1998.
4. Troller J. Attention deficit disorder in adults: conceptual and clinical issues. Med J Aust 1999;171(8)421-5.
5. Biederman J. Attention deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry 1998;59(Suppl 7):4-16.
6. Roy-Byrne P, Scheele L, Brinkley J, Ward N, Wiatrak C, Russo J, et al. Adult attention deficit hyperactivity disorder: assessment guidelines based on clinical presentation in a specialty clinic. Compr Psychiatry 1997;38(3):133-40.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1992. p. 83-5.
8. Barkley R, Murphy K. ADHD, a clinical workbook. 2nd ed. New York, NY: Guildford Press; 1998.
9. Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psych Clin North Am 2004;27(2):187-201.
10. Wender PH. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry 1998;59(Suppl 7):76-9.
11. Weiss M, Trokenberg-Hechtman L, Weiss G. ADHD in adulthood: a guide to current theory, diagnosis, and treatment. Baltimore, Md: John Hopkins University Press; 1999.
12. Spencer T, Biederman J, Wilens T, Faraone S. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002;63(Suppl 12):3-9.
13. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 2003;168(6):715-22.
14. Barkley R. ADHD and the nature of self-control. New York, NY: Guildford Press; 1997.
15. Castellanos F. Psychobiology of ADHD. In: Quay H, Flynn A, editors. Handbook of disruptive behavior disorders. New York, NY: Plenum; 2000. p. 179-98.
16. Arcia E, Conners CK. Gender differences in ADHD? J Dev Behav Pediatr 1998;19(2):77-83.
17. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993;150(12):1792-8.
18. Hornig M. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 1998;59(suppl 7):69-75.
19. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150(6 ):885-90.
20. Brown TE. Brown attention-deficit disorder scales manual San Antonio, Tex: Harcourt Brace and Company; 1996.
21. Conners CK, Erhardt D, Sparrow EP. Conners adult ADHD rating scales. Technical manual. New York, NY: Multi-Health Systems; 1999.
22. Hallowell EM, Ratey J. Driven to distraction: recognizing and coping with attention deficit disorder from childhood through adulthood. New York, NY: Pantheon Books; 1994.
23. Mannuzza S, Klein RG, Klein DF, Besslere A, Shrout P. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 2002;159(11):1882-8.
24. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameter for the use of stimulant medication in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry 2002;41(Suppl 2):26-49S.
25. Wilens T, McDermott S. Cognitive therapy for adults with attention deficit/hyperactivity disorder. In: Brown TE, editor. Attention-deficit disorders and camorbidities in children, adolescents, and adults. Washington, DC: American Psychiatric Press; 2000. p. 569-607.
26. Bemporad JR. Aspects of psychotherapy with adults with attention deficit disorder. Ann N Y Acad Sci 2001;931:302-9.
27. Murphy K. Empowering the adult with ADD. In: Nadeau K, editor. A comprehensive guide to attention deficit disorder in adults New York, NY: Brunner/Mazel; 1995. p. 101-17.
28. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Atten Disord 2002;5(4):189-202.
29. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004;24(1):24-9.
30. Swanson J, Greenhill LL, Pelham W, Wolraich ML, Wilens T, Palumbo D, et al. Initiating Concerta (OROS methylphenidate HCI) qd in children with attention-deficit hyperactivity disorder. J Clin Res 2000;3:59-76.
31. Faraone SV, Biederman J. Efficacy of Adderall for attention-deficit/hyperactivity disorder: a meta-analysis. J Atten Disord 2002;6(2):69-75.
32. Michelson D, Adler, L, Spencer T, Reimherr FW, West FA, Allen AJ, et al. Atomoxitene in adults with ADHD: two randomised, placebo-controlled studies. Biol Psychiatry 2003;53(2):112-20.
33. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001;158(2):282-8.
34. Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, et al. Buproprion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 2001;13(3):129-34.
35. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996;153(9):1147-53.
36. Hornig-Rohan M, Amsterdam J. Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression. Prog Neuropsychopharmacol Biol Psychiatry 2002;26(3):585-9.
37. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann N Y Acad Sci 2001;931:1-16.